Publication | Closed Access

Eicosapantaenoic acid treatment based on the EPA/AA ratio in patients with coronary artery disease: follow-up data from the Tochigi Ryomo EPA/AA Trial in Coronary Artery Disease (TREAT-CAD) study

Cardiovascular DiseaseEicosapantaenoic Acid TreatmentPharmacologyEpa/aa RatioPharmacotherapyMedicineAtherosclerosisCoronary Artery DiseaseMyocardial Infarction